| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Schlackman Scott serves as a Director at MED. Across recent SEC filings that breaks down to 7 buys and 10 sells. Those positions are worth an estimated $356K at current prices.
Historically, Schlackman Scott's trades have earned a middling insider score of 60/100 across 8 rated trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of -17.4%.
The biggest single holding is MED (~$356K) as Director. The recent filings there lean toward selling, a net 9,746 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2019 | MED Medifast Inc | Director | Sell | 2,000 | $130.92 | $261,844.30 | -13.2% | |
| Mar 5, 2019 | MED Medifast Inc | Director | Sale+OE | 2,500 | $129.80 | $324,500.00 | -23.7% |